Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001179110-21-008584 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-03 | 2021-09-02 | PTCT | Boulding Mark Elliott | EVP, CLO | M - OptEx | $18.01 | +3,363 | 51.7K | +7% | +$60.6K |
| D | 2021-09-03 | 2021-09-02 | PTCT | Boulding Mark Elliott | EVP, CLO | S - Sale+OE | $45.01 | -3,363 | 48.4K | -7% | -$151.4K |
| D | 2021-09-03 | 2021-09-02 | PTCT | Boulding Mark Elliott | EVP, CLO | M - OptEx | $18.01 | -3,363 | 15.7K | -18% | -$60.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-02 | M | A | 3,363 | $18.01 | 51,737 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-02 | S | D | 3,363 | $45.01 | 48,374 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-02 | M | D | 3,363 | $18.01 | 15,653 | D | $18.01 · — to 2028-01-02 | 3,363 Common Stock | (F3) This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. |